دورية أكاديمية

A ten-gene DNA-damage response pathway gene expression signature predicts gemtuzumab ozogamicin response in pediatric AML patients treated on COGAAML0531 and AAML03P1 trials

التفاصيل البيبلوغرافية
العنوان: A ten-gene DNA-damage response pathway gene expression signature predicts gemtuzumab ozogamicin response in pediatric AML patients treated on COGAAML0531 and AAML03P1 trials
المؤلفون: Gbadamosi, Mohammed O., Shastri, Vivek M., Elsayed, Abdelrahman H., Ries, Rhonda, Olabige, Oluwaseyi, Nguyen, Nam H. K., De Jesus, Angelica, Wang, Yi-Cheng, Dang, Alice, Hirsch, Betsy A., Alonzo, Todd A.Aff3, Aff5, Gamis, Alan, Meshinchi, Soheil, Lamba, Jatinder K.Aff1, Aff7, IDs41375022016220_cor14
المصدر: Leukemia. 36(8):2022-2031
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:08876924
14765551
DOI:10.1038/s41375-022-01622-0